Alioth

About:

Alioth focuses on the development and application of technical products for pharmaceutical process technology.

Website: https://www.aliothbio.com

Top Investors: Legend Capital, Matrix Partners China, AstraZeneca CICC Medical Industry Fund, Yi Shuishuishan

Description:

Elios focusing on the development and application of pharmaceutical process technology and related products. The company is dedicated to providing high-quality separation and purification solutions that comply with domestic and international regulations to pharmaceutical companies. In order to meet GMP requirements, Elios established its own production bases in Lingang, Shanghai, and Hangzhou. It has process development labs, verification labs, and filtration product R&D centers, as well as a research and development team led by membrane technology scientists to better safeguard supply chain security.

Total Funding Amount:

190M CNY

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2021-01-01

Contact Email:

marketing(AT)aliothbio.com

Founders:

Number of Employees:

51-100

Last Funding Date:

2023-10-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai